1. Home
  2. MYFW vs CMPX Comparison

MYFW vs CMPX Comparison

Compare MYFW & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MYFW

First Western Financial Inc.

HOLD

Current Price

$26.25

Market Cap

220.8M

Sector

Finance

ML Signal

HOLD

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

HOLD

Current Price

$5.17

Market Cap

752.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MYFW
CMPX
Founded
2002
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
220.8M
752.4M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
MYFW
CMPX
Price
$26.25
$5.17
Analyst Decision
Buy
Strong Buy
Analyst Count
2
10
Target Price
$24.25
$13.44
AVG Volume (30 Days)
30.6K
2.0M
Earning Date
01-22-2026
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
391.62
N/A
EPS
1.28
N/A
Revenue
$95,514,000.00
N/A
Revenue This Year
$15.96
N/A
Revenue Next Year
$13.77
N/A
P/E Ratio
$20.41
N/A
Revenue Growth
19.92
N/A
52 Week Low
$17.10
$1.33
52 Week High
$26.50
$5.86

Technical Indicators

Market Signals
Indicator
MYFW
CMPX
Relative Strength Index (RSI) 69.47 52.90
Support Level $25.91 $4.83
Resistance Level $26.33 $5.27
Average True Range (ATR) 0.51 0.27
MACD 0.02 -0.05
Stochastic Oscillator 82.22 33.51

Price Performance

Historical Comparison
MYFW
CMPX

About MYFW First Western Financial Inc.

First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.

Share on Social Networks: